Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a high mortality. However, the treatment options for advanced HCC are limited to tyrosine kinase inhibitors, such as sorafenib and lenvatinib. Since previous regimens have an insufficient efficacy, the com...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Su Hyeon, You, Ga Ram, Park, Chan, Cho, Sang-Geon, Lee, Jong Eun, Choi, Sung Kyu, Cho, Sung Bum, Yoon, Jae Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237029/
https://www.ncbi.nlm.nih.gov/pubmed/37275450
http://dx.doi.org/10.4251/wjgo.v15.i5.892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237029/
https://www.ncbi.nlm.nih.gov/pubmed/37275450
http://dx.doi.org/10.4251/wjgo.v15.i5.892

Ejemplares similares